logo Sona17th International Conference of the Society of Neuroscientists of Africalogo_Amn
Marrakesh-Morocco
April, 17-20, 2025

Symposium 23
Title: Epidemiology, physiopathological and therapeutic aspects of multiple sclerosis: an emerging disease in Africa
Organizer:
FATIHA CHIGR &  Samir  AHBOUCHA
FST, USMS, B.P. 523, code postal 23000, Beni-Mellal, Morocco
FPK, USMS, P.B :145, code postal 25000 Khouribga, Morocco
email: f.chigr@usms.ma; s.ahboucha@usms.ma


Abstract
:

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system that typically affect young adults, especially women. Recently several body of evidence suggests that many neuro-inflammatory and neurodegenerative diseases are increasing in Africa and middle Est including MS. The aim the proposed symposium is to shed light on MS disease and address an update of the epidemiological and clinical aspects of MS in Morocco and Africa. The
symposium will address particular symptoms that affect MS patients including fatigue and depression and their relationship with disease severity. So far, the pathophysiologic mechanisms for MS were not fully elucidated although inflammatory, systemic, blood brain barrier, immune system, vascular, neuromodulatory, and demyelinating mechanisms where suggested to play a role. The symposium will also address potential therapeutic aspects and possible pathophysiological components involving the role of adenosinergic and serotoninergic systems in experimental model of chronic MS.

Speakers
Number
Speaker
e-mail
Title of  the communication
SP23_1
Fatiha Chigr
f.chigr@usms.ma
Multiple sclerosis in Morocco: Epidemiological, clinical, and therapeutic profile.
SP23_2
Rachid Lotfi
r.lotfi@usms.ma
Impact of multiple sclerosis on patients' quality of life in Morocco
SP23_3
Olamide E Adebiyi
olamideadebiyi24@gmail.com
Rescuing cognitive dysfunction in a mouse model of hippocampal demyelination
SP23_4 Samir Ahboucha s.ahboucha@usms.ma Alterations in the serotonergic system and mood behaviors in a cuprizone-induced mouse model of multiple sclerosis